Article info
Original article
SP3, a reliable alternative to HercepTest in determining HER-2/neu status in breast cancer patients
- Correspondence to Dr Timothy Michael D'Alfonso, Department of Pathology and Laboratory Medicine, New York-Presbyterian Hospital/Weill Cornell Medical College, 525 East 68th Street, Starr 1000, New York, NY 10065, USA; tid9007{at}med.cornell.edu
Citation
SP3, a reliable alternative to HercepTest in determining HER-2/neu status in breast cancer patients
Publication history
- Received October 10, 2012
- Revised November 19, 2012
- Accepted January 8, 2013
- First published February 5, 2013.
Online issue publication
April 21, 2013
Article Versions
- Previous version (5 February 2013).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions